Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 5
2005 8
2006 10
2007 14
2008 31
2009 11
2010 7
2011 15
2012 35
2013 61
2014 47
2015 31
2016 45
2017 36
2018 31
2019 37
2020 55
2021 58
2022 59
2023 93
2024 36

Text availability

Article attribute

Article type

Publication date

Search Results

619 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Ikegami T, Yoshizumi T, Iseda N, Toshima T, Elshawy ME, Mori M. Ikegami T, et al. Among authors: yoshizumi t. Liver Transpl. 2020 Mar;26(3):463-464. doi: 10.1002/lt.25702. Epub 2020 Feb 7. Liver Transpl. 2020. PMID: 31838772 No abstract available.
Reply.
Takeishi K, Ikegami T, Yoshizumi T, Fujimori N, Mori M. Takeishi K, et al. Among authors: yoshizumi t. Liver Transpl. 2020 May;26(5):727-728. doi: 10.1002/lt.25725. Epub 2020 Feb 25. Liver Transpl. 2020. PMID: 31997556 No abstract available.
Modulation of host glutamine anabolism enhances the sensitivity of small cell lung cancer to chemotherapy.
Kodama M, Toyokawa G, Sugahara O, Sugiyama S, Haratake N, Yamada Y, Wada R, Takamori S, Shimokawa M, Takenaka T, Tagawa T, Kittaka H, Tsuruda T, Tanaka K, Komatsu Y, Nakata K, Imado Y, Yamazaki K, Okamoto I, Oda Y, Takahashi M, Izumi Y, Bamba T, Shimizu H, Yoshizumi T, Nakayama KI. Kodama M, et al. Among authors: yoshizumi t. Cell Rep. 2023 Aug 29;42(8):112899. doi: 10.1016/j.celrep.2023.112899. Epub 2023 Aug 1. Cell Rep. 2023. PMID: 37531252 Free article.
Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors.
Suzuki H, Iwamoto H, Seki T, Nakamura T, Masuda A, Sakaue T, Tanaka T, Imamura Y, Niizeki T, Nakano M, Shimose S, Shirono T, Noda Y, Kamachi N, Sakai M, Morita K, Nakayama M, Yoshizumi T, Kuromatsu R, Yano H, Cao Y, Koga H, Torimura T. Suzuki H, et al. Among authors: yoshizumi t. Cancer Commun (Lond). 2023 Apr;43(4):415-434. doi: 10.1002/cac2.12411. Epub 2023 Feb 24. Cancer Commun (Lond). 2023. PMID: 36825684 Free PMC article.
Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications.
Toyokawa G, Bersani F, Bironzo P, Picca F, Tabbò F, Haratake N, Takenaka T, Seto T, Yoshizumi T, Novello S, Scagliotti GV, Taulli R. Toyokawa G, et al. Among authors: yoshizumi t. Crit Rev Oncol Hematol. 2023 Apr;184:103966. doi: 10.1016/j.critrevonc.2023.103966. Epub 2023 Mar 15. Crit Rev Oncol Hematol. 2023. PMID: 36925092 Free article. Review.
MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.
Haratake N, Ozawa H, Morimoto Y, Yamashita N, Daimon T, Bhattacharya A, Wang K, Nakashoji A, Isozaki H, Shimokawa M, Kikutake C, Suyama M, Hashinokuchi A, Takada K, Takenaka T, Yoshizumi T, Mitsudomi T, Hata AN, Kufe D. Haratake N, et al. Among authors: yoshizumi t. J Thorac Oncol. 2024 Mar;19(3):434-450. doi: 10.1016/j.jtho.2023.10.017. Epub 2023 Nov 3. J Thorac Oncol. 2024. PMID: 37924972 Free article.
MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.
Yamashita N, Morimoto Y, Fushimi A, Ahmad R, Bhattacharya A, Daimon T, Haratake N, Inoue Y, Ishikawa S, Yamamoto M, Hata T, Akiyoshi S, Hu Q, Liu T, Withers H, Liu S, Shapiro GI, Yoshizumi T, Long MD, Kufe D. Yamashita N, et al. Among authors: yoshizumi t. Mol Cancer Res. 2023 Mar 1;21(3):274-289. doi: 10.1158/1541-7786.MCR-22-0772. Mol Cancer Res. 2023. PMID: 36445328 Free PMC article.
MicroRNA-326 negatively regulates CD155 expression in lung adenocarcinoma.
Nakanishi T, Yoneshima Y, Okamura K, Yanagihara T, Hashisako M, Iwasaki T, Haratake N, Mizusaki S, Ota K, Iwama E, Takenaka T, Tanaka K, Yoshizumi T, Oda Y, Okamoto I. Nakanishi T, et al. Among authors: yoshizumi t. Cancer Sci. 2023 Oct;114(10):4101-4113. doi: 10.1111/cas.15921. Epub 2023 Aug 10. Cancer Sci. 2023. PMID: 37565582 Free PMC article.
619 results